Pathological findings in early-stage endometrial cancer

Objective: The aim of this study was to assess the pathological characteristics of early-stage endometrial cancer, with regard to endometrioid versus serous papillary adenocarcinoma.

Methods: Sixty-six cases of early-stage endometrial carcinoma were classified into two groups: group I--36 cases of endometrioid endometrial cancer, staged IA-IB and graded G1-G2; group II--30 cases of Stage I serous papillary endometrial cancer. The pathological characteristics compared between the two groups included features such as tumor location in the uterine cavity, tumor focality, lymphovascular invasion, as well as the status of the uninvolved endometrium, adjacent to the tumor. Patient clinical characteristics were obtained from the medical records.

Results: Significantly more patients with endometrioid endometrial cancer were premenopausal (p < 0.0001), obese (p < 0.02), had hypertension (p < 0.00001) and familial cancer (p < 0.0001). On the other hand, significantly more patients with serous papillary cancer had another primary malignancy (p < 0.001). Considering the pathological characteristics, 75% of endometrioid as compared with 6.7% of serous papillary cancer cases were found in the upper uterine segment only (p < 0.0001). Multifocality was observed in 16.7% of endometrioid as compared with 100% of serous papillary cancer cases (p < 0.0001). Lymphovascular space invasion was absent in all cases of endometrioid cancer, while present in 90% of serous papillary cancer cases (p < 0.0001). Seventy-five percent of endometrioid and 100% of serous papillary cancer cases were associated with an atrophic endometrium.

Conclusion: The clinical and pathological features of early-stage endometrial cancer differ according to the histological type of the cancer. The majority of endometrioid cancers are probably associated with an atrophic or normally cycling endometrium, and not with endometrial hyperplasia.

Early-stage endometrial cancer; Endometrioid endometrial cancer; Serous papillary endometrial cancer; Clinicopathological findings; Endometrial hyperplasia; Atrophic endometrium

[1] Rose P. G.: "Endometrial carcinoma". N. Engl. J. Med., 1996, 335, 640.

[2] Burton J. L., Wells M.: "Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium" Histopathology, 1998, 33, 297.

[3] Kurman R. J., Zaino R. J., Norris N. J.: "Endometrial Carcinoma" In: Blaustein's Pathology of the Female Genital Tract. R. J. Kurman (ed), New York, Springer-Verlag, 1994, 439.

[4] Deligdisch L., Cohen C. J.: "Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia". Cancer, 1985, 56, 1452.

[5] Bokhman J. V.: "Two pathogenetic types of endometrial carcinoma". Gynecol. Oneal., 1983, 15, 10.

[6] Ayhan A., Yarali H., Ayhan A.: "Endometrial carcinoma: A pathologic evaluation of 142 cases with and without associated endometrial hyperplasia". J. Surg. Oneal., 1991, 46, 182

[7] Carcangiu M. L., Chambers J. T.: "Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival" Int. J. Gynecol. Pathol., 1995, 14, 30.

[8] Ohkawara S., Jobo T., Sato R., Kuramoto H.: "Comparison of endometrial carcinoma coexisting with and without endometrial hyperplasia". Eur. J. Gynecol. Oneal., 2000, 27, 573.

[9] Sivridis E., Fox H., Buckley C. H.: "Endometrial carcinoma: two or three entities?". Int. J. Gynecol. Cancer, 1998, 8, 183.

[10] Sivridis E., Giatromanolaki A.: "Prognostic aspects on endometrial hyperplasia and neoplasia". Virchows Arch., 2001, 439, 118.

[11] Westhoff C., Heller D., Drosinos S., Tancer L.: "Risk factors for hyperplasia-associated versus atrophy-associated endometrial carcinoma". Am. J. Obstet. Gynecol., 2000, 182, 506.

[12] Creasman W.: "Announcement. FIGO stages - 1988 revision". Gynecol. Oneal., 1989, 35, 125.

[13] Scully R. E., Kurman R. J., Silverberg S. G.: "Histological typrng of female genital tract tumors". 2"ct Ed. WHO International Histological Classification of Tumors. Berlin, Springer-Verlag, 1994.

[14] Kurman R. J., Zaino R. J., Norris H.J.: "Endometrial carcinoma". In: Blausteins's Pathology of the Female Genital Tract, R. J. Kurman (ed.). New York, Springer-Verlag, 1994, 439.

[15] Deligdisch L., Holinka C. F.: "Endometrial carcinoma: two diseases?". Cancer Detect. Prev., 1987, 10, 237.

[16] Beckner M. E., Mori T., Silverberg S. G.: "Endometrial carcinoma: on- tumor factors in prognosis". Int. J. Gynecol. Pathol., 1985, 4, 131

[17] Phelan C., Montag A. G., Rotrnensch J., Waggoner S. E., Yamada S. D., Mundt A. J.: "Outcome and management of pathological stage I endometrial carcinoma patients with involvement of the lower uterine segment". Gynecol. Oneal., 2001, 83, 513.

[18] Ambros R. A., Sherman M. E., Zahn C. M., Bitterman P., Kurman R. J.: "Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumours displaying serous differentiation". Hum. Pathol., 1995, 26, 1260.

[19] Kaku T., Tsukamoto N., Hachisuga T., Tsuruchi N., Sakai K., Hirakawa T. et al.: "Endometrial carcinoma associated with hyperplasia". Gynecol. Oneal., 1996, 60, 22.